Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Romiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids

dc.contributor.authorCasanovas Taltavull, Teresa
dc.contributor.authorPeña Cala, Maria Carmen
dc.date.accessioned2018-09-12T12:28:05Z
dc.date.available2018-09-12T12:28:05Z
dc.date.issued2017-02-01
dc.date.updated2018-07-24T12:11:16Z
dc.description.abstractKey Clinical Message: Our case report discusses the usefulness of administering romiplostim as a second-line treatment before splenectomy in a cirrhotic patient with immune thrombocytopenia who developed corticosteroid-induced Cushing's syndrome. Corticosteroids were tapered and consequently withdrawn. The patient made a full recovery postsplenectomy.
dc.format.extent5 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid28174643
dc.identifier.urihttps://hdl.handle.net/2445/124486
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1002/ccr3.667
dc.relation.ispartofClinical Case Reports, 2017, vol. 5, num. 2, p. 159-163
dc.relation.urihttps://doi.org/10.1002/ccr3.667
dc.rightscc by (c) Casanovas Taltavull, Teresa; Peña Cala, Maria Carmen, 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationSíndrome de Cushing
dc.subject.classificationAdministració de medicaments
dc.subject.otherCushing's syndrome
dc.subject.otherAdministration of drugs
dc.titleRomiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
TaltavullTC.pdf
Mida:
374.84 KB
Format:
Adobe Portable Document Format